442 Pre-treatment interstitial abnormalities is a risk factor for immune checkpoint inhibitor pneumonitis in patients with lung cancer

Regular and Young Investigator Award Abstracts(2022)

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要